These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 24149930)
1. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause. Pinkerton JV; Kagan R; Portman D; Sathyanarayana R; Sweeney M; Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930 [TBL] [Abstract][Full Text] [Related]
2. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Sang CN; Sathyanarayana R; Sweeney M; Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243 [TBL] [Abstract][Full Text] [Related]
3. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Butt DA; Lock M; Lewis JE; Ross S; Moineddin R Menopause; 2008; 15(2):310-8. PubMed ID: 17917611 [TBL] [Abstract][Full Text] [Related]
4. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Toulis KA; Tzellos T; Kouvelas D; Goulis DG Clin Ther; 2009 Feb; 31(2):221-35. PubMed ID: 19302896 [TBL] [Abstract][Full Text] [Related]
5. Use of gabapentin for the management of natural or surgical menopausal hot flashes. Hayes LP; Carroll DG; Kelley KW Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402 [TBL] [Abstract][Full Text] [Related]
6. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054 [TBL] [Abstract][Full Text] [Related]
8. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies. Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085 [TBL] [Abstract][Full Text] [Related]
9. A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial. Sandercock D; Cramer M; Biton V; Cowles VE Diabetes Res Clin Pract; 2012 Sep; 97(3):438-45. PubMed ID: 22497967 [TBL] [Abstract][Full Text] [Related]
10. Use of gabapentin in patients experiencing hot flashes. Brown JN; Wright BR Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over. Gupta A; Li S Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280 [TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms. Cowles VE; Gordi T; Hou SY Clin Drug Investig; 2012 Sep; 32(9):593-601. PubMed ID: 22775354 [TBL] [Abstract][Full Text] [Related]
13. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. Parsons B; Tive L; Huang S Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647 [TBL] [Abstract][Full Text] [Related]
14. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. Yurcheshen ME; Guttuso T; McDermott M; Holloway RG; Perlis M J Womens Health (Larchmt); 2009 Sep; 18(9):1355-60. PubMed ID: 19708803 [TBL] [Abstract][Full Text] [Related]
15. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients. Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075 [TBL] [Abstract][Full Text] [Related]
16. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Biglia N; Sgandurra P; Peano E; Marenco D; Moggio G; Bounous V; Tomasi Cont N; Ponzone R; Sismondi P Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540 [TBL] [Abstract][Full Text] [Related]
17. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial. Pinkerton JV; Constantine G; Hwang E; Cheng RF; Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882 [TBL] [Abstract][Full Text] [Related]
19. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes. Aguirre W; Chedraui P; Mendoza J; Ruilova I Gynecol Endocrinol; 2010 May; 26(5):333-7. PubMed ID: 20050764 [TBL] [Abstract][Full Text] [Related]
20. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB. Moraska AR; Atherton PJ; Szydlo DW; Barton DL; Stella PJ; Rowland KM; Schaefer PL; Krook J; Bearden JD; Loprinzi CL J Support Oncol; 2010; 8(3):128-32. PubMed ID: 20552926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]